Liberty Bio is a startup drug development company. Our first project is a novel therapeutic for polycystic kidney disease (PKD). We are working to bring drug candidates through Phase I (animal model efficacy, human safety) and in the process gather data which will allow us to finalize and obtain our patent. At that time, we would seek out a partnership or buyout with a large pharma company.